Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Argent Biopharma ( (AU:RGT) ) has shared an announcement.
Argent Biopharma Limited announced the cancellation of a previous securities quotation application due to a required amendment to the issue price. This adjustment reflects the company’s commitment to compliance with ASX Listing Rules, potentially impacting its market operations and investor relations.
More about Argent Biopharma
Argent Biopharma Limited operates in the biopharmaceutical industry, focusing on the development and commercialization of innovative therapies. The company is listed on the Australian Securities Exchange under the issuer code RGT.
YTD Price Performance: -20.83%
Average Trading Volume: 554
Technical Sentiment Signal: Buy
Current Market Cap: $6.82M
See more insights into RGT stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue